Roche to acquire U.S.-Based Gene Therapy Specialist Spark @ $4.8 Billion
Swiss drugmaker Roche agreed to buy Philadelphia-based Spark Therapeutics for $4.8 billion. Spark works to create gene therapies for genetic diseases, including... Read More
Novartis licenses lipoprotein-lowering CVD drug AKCEA-APO(a)-LRx
Posted on26 Feb 2019
Comments0
Excited by strong phase II data, Novartis is exercising its option to license Akcea Therapeutics’ AKCEA-APO(a)-LRx, a treatment to reduce the risk... Read More
Key Understanding on Price monitoring and research units (PMRUs) intiative in India
PMRUs intitative is adopted by The National Pharmaceutical Pricing Authority (NPPA). Under the initiative NPPA facilitates price monitoring and research units (PMRUs)... Read More
3M India and CRF to jointly educate pulmonologists on chronic respiratory disorders in India
3M India has signed a memorandum of understanding with Chest Research Foundation (CRF) to collaborate on a research study to generate data... Read More
Merck to acquire immunotherapy company, Immune Design for US$ 300 million
Merck and Immune Design announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire... Read More
Abbott, Novo Nordisk partner to provide integrated digital solution to people with diabetes using insulin
Abbott, a global healthcare leader and Novo Nordisk announced a non-exclusive partnership that will integrate insulin dose data from Novo Nordisk pre-filled... Read More
Serum Institute launched immunisation awareness drive in India
Posted on22 Feb 2019
Comments0
Serum Institute of India, one of the world’s largest vaccine manufacturers, has roped in noted actress Kareena Kapoor Khan as the brand... Read More
USFDA approves Novo Nordisk’s Esperoct for haemophilia A treatment
Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved the Biologics License Application for Esperoct for the treatment... Read More
NuVasive’s Precice Bone Transport System receives US FDA & European approvals for use in segmental bone loss treatment
NuVasive, the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced it received 510(k)... Read More
GSK’s disinvestment of Chiron Behring to Bharat Biotech
Posted on16 Feb 2019
Tagsacquisition in pharma, Bharat Biotech, Chiron Behring Vaccines, disinvestment in pharma business, GSK, Hoechst AG
Comments0
Bharat Biotech’s recent plans to acquire Chiron Behring Vaccine Private Limited from GlaxoSmithKline Asia, is expected to boost the company’s rabies vaccine... Read More